Back
Edesa Biotech Vs. Aurinia Pharmaceuticals Industry Stock Comparison
Sell
31
EDSA
Edesa Biotech
Last Price:
4.23
Seasonality Move:
20.85%
Sell
45
AUPH
Aurinia Pharmaceuticals
Last Price:
5.48
Seasonality Move:
-0.92%
Sell
31
Edesa Biotech (EDSA)
is a Sell
Is Edesa Biotech a Buy, Sell or Hold?
- The current Edesa Biotech [EDSA] share price is $4.21. The Score for EDSA is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
- EDSA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
45
Aurinia Pharmaceuticals (AUPH)
is a Sell
Is Aurinia Pharmaceuticals a Buy, Sell or Hold?
- The current Aurinia Pharmaceuticals [AUPH] share price is $5.43. The Score for AUPH is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- AUPH is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
EDSA Stock Price Chart
What is Edesa Biotech's stock price today?
-
The Edesa Biotech share price today is $4.21
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EDSA is experiencing selling pressure, which indicates risk of future bearish movement.
AUPH Stock Price Chart
What is Aurinia Pharmaceuticals's stock price today?
-
The Aurinia Pharmaceuticals share price today is $5.43
The current trend is moderately bearish and AUPH is experiencing selling pressure, which indicates risk of future bearish movement.
EDSA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.05 | Sell |
Relative Strength Index (14 RSI): | 43.31 | Sell |
Chaikin Money Flow: | -2737 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (4.26 - 4.54) | Sell |
Bollinger Bands (100): | (4.23 - 4.83) | Sell |
AUPH Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.05 | Buy |
Relative Strength Index (14 RSI): | 48.77 | Sell |
Chaikin Money Flow: | -479572 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (5.32 - 5.58) | Sell |
Bollinger Bands (100): | (4.81 - 6.13) | Sell |
EDSA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 4.31 | Sell |
20-day SMA: | 4.41 | Sell |
50-day SMA: | 4.45 | Sell |
200-day SMA: | 4.38 | Sell |
8-day EMA: | 4.31 | Sell |
20-day EMA: | 4.36 | Sell |
50-day EMA: | 4.42 | Sell |
200-day EMA: | 4.92 | Sell |
AUPH Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.56 | Sell |
20-day SMA: | 5.49 | Sell |
50-day SMA: | 5.34 | Buy |
200-day SMA: | 6.83 | Sell |
8-day EMA: | 5.53 | Sell |
20-day EMA: | 5.49 | Sell |
50-day EMA: | 5.46 | Sell |
200-day EMA: | 6.65 | Sell |
Edesa Biotech Earnings Growth & EDSA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Aurinia Pharmaceuticals Earnings Growth & AUPH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.65 per share, and an increase next year of $0.35 per share.
Edesa Biotech Technical Analysis
Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | Jul 2 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | 01 | 02 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Aurinia Pharmaceuticals Technical Analysis
Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | Jul 2 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | 01 | 02 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |